Further study showed that G-CSF released from LLC tumor increased more activated CD11bhigh neutrophils and NETs than B16 tumor, and B16 tumors in WT mice grew faster than the tumors in PAD4-deficient mice after G-CSF treatment (94). The gene discussed is CSF3; the disease is neoplasm.